Furthermore, FGF-23 was higher in adults with normal BMI and abdominal obesity, indicating an increased metabolic and cardiovascular risk [49], as well as in adolescents with obesity and those with cardiac hypertrophy, suggesting that it may be an early marker of cardiac injury in adolescents with obesity [50]. The gene discussed is FGF23; the disease is Abdominal obesity.